title: Mechanism of action of ribavirin in the combination treatment of chronic HCV infection.
authors: Research and Development, ICN Pharmaceuticals Inc., Costa Mesa, CA 92626, USA. jlau@icnpharm.com
authors: Johnson Y N
authors: JY
authors: Lau
authors: Robert C
authors: RC
authors: Tam
authors: T Jake
authors: TJ
authors: Liang
authors: Zhi
authors: Z
authors: Hong
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology*; D004359:Drug Therapy, Combination; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D016898:Interferon-alpha / Q000494:pharmacology; D012254:Ribavirin / Q000494:pharmacology*
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin